These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755 [TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [TBL] [Abstract][Full Text] [Related]
7. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Ogami M; Ikura Y; Nishiguchi S; Kuroki T; Ueda M; Sakurai M Lab Invest; 1999 Jan; 79(1):15-26. PubMed ID: 9952107 [TBL] [Abstract][Full Text] [Related]
9. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC]. Dai D; Zhai W; Zhu T; Zhu H; Ling Y Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149 [TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of hepatomas and circulating telomerase and its clinical values. Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259 [TBL] [Abstract][Full Text] [Related]
11. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997 [TBL] [Abstract][Full Text] [Related]
12. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53]. Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of telomerase activity in resected hepatocellular carcinoma. Kanamaru T; Yamamoto M; Morita Y; Itoh T; Kuroda Y; Hisatomi H Int J Mol Med; 1999 Sep; 4(3):267-71. PubMed ID: 10425277 [TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Tahara H; Nakanishi T; Kitamoto M; Nakashio R; Shay JW; Tahara E; Kajiyama G; Ide T Cancer Res; 1995 Jul; 55(13):2734-6. PubMed ID: 7796395 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of telomerase activity in hepatocellular carcinoma. Ohta K; Kanamaru T; Yamamoto M; Saitoh Y Kobe J Med Sci; 1996 Jun; 42(3):207-17. PubMed ID: 8973088 [TBL] [Abstract][Full Text] [Related]
17. Telomerase and c-myc expression in hepatocellular carcinomas. Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891 [TBL] [Abstract][Full Text] [Related]
18. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. Zhang X; Dong N; Zhang H; You J; Wang H; Ye L J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653 [TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Lee CM; Hsu CY; Eng HL; Huang WS; Lu SN; Changchien CS; Chen CL; Cho CL Hepatogastroenterology; 2004; 51(57):796-800. PubMed ID: 15143919 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]